Company Overview
- Website
- glycopath.com
- Employees
- 5
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$3B
Recent News & Media
An innovation journey: How MUSC helped bring GlycoPath to life
- Dec 6, 2024
- web.musc.edu
Spatial omics-based machine learning algorithms for the early detection of hepatocellular carcinoma
- Dec 3, 2024
- nature.com
GlycoFibroTyper: A Novel Method for the Glycan Analysis of IgG and the Development of a Biomarker Signature of Liver Fibrosis
- Nov 13, 2024
- pmc.ncbi.nlm.nih.gov
Acute Lyme disease IgG N-linked glycans contrast the canonical inflammatory signature
- Nov 10, 2024
- pmc.ncbi.nlm.nih.gov
Richard Drake, PhD's Profile Page
- Oct 31, 2024
- technologynetworks.com
Optimized protocol for MALDI MSI of N-glycans using an on-tissue digestion in fresh frozen tissue sections
- Feb 16, 2023
- nature.com
Companies Similar to GlycoPath Inc
Analyze industry trends and opportunities by examining competitors and companies comparable to GlycoPath Inc, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | 2 | Cambridge, MA | 2005 | |
| 3M | 7 | New York, NY | 2008 | |
| 3M | 3 | New York, NY | ||
| 3M | 2 | Knoxville, TN | 2004 | |
| 3M | 35 | Austin, TX |